Rising Claims And Costly Integrations Will Hinder Brazil's Healthcare Delivery
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
03 Jul 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
R$31.50
25.0% overvalued intrinsic discount16 Aug
R$39.37
1Y
-42.4%7D
10.6%